What's Next: Orforglipron (oral GLP-1) completing Phase 3 trials with submissions expected by year-end 2025 CEO Dave Ricks expects FDA approval by March 2026 International launches accelerating in China, Brazil, India, and Mexico The GLP-1 market is projected to exceed $100B+ by the early 2030s, and Lilly is positioned as the category leader
A study on rats fed either a control diet, a diet supplemented with carnitine, or a diet of lamb meat found that the carnitine in the lamb, though in lower concentrations than the supplemented diet, was more effective at reducing fat in the liver
Remember, consistency and pairing it with a healthy lifestyle will always give you the best overall results
To understand what actually shapes long-term health, you need to step back and look at how these layers interact
Our bodies do produce reduced glutathione naturally, but that production declines as we age
These will lead to various symptoms of irritation such as itch, erythema, edema and pain